Head to head: should the intraductal component of invasive prostate cancer be graded?

Varma, Murali and Epstein, Jonathan I 2020. Head to head: should the intraductal component of invasive prostate cancer be graded? Histopathology 78 (2) , pp. 231-239. 10.1111/his.14216

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial. Download (2MB) | Preview

Abstract

The reporting of intraductal carcinoma of the prostate (IDCP) is controversial, with conflicting recommendations having recently been published by the International Society of Urological Pathology (ISUP) and the Genitourinary Pathology Society (GUPS). Both recommend that isolated (pure) IDCP should not be graded. However, the ISUP recommends incorporating the IDCP component of invasive prostate cancer in the Gleason score, whereas the GUPS recommends reporting IDCP as a comment, independently of the Gleason score. The arguments for and against incorporating the IDCP component of invasive prostate cancer in the Gleason score are discussed in detail.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Wiley
ISSN:	0309-0167
Date of First Compliant Deposit:	14 May 2021
Date of Acceptance:	16 July 2020
Last Modified:	05 May 2023 09:47
URI:	https://orca.cardiff.ac.uk/id/eprint/141338

Citation Data

Cited 16 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item